Variable effect of growth hormone on growth and final adult height in Scottish patients with Turner's syndrome

被引:27
作者
Chu, CE
Paterson, WF
Kelnar, CJH
Smail, PJ
Greene, SA
Donaldson, MDC
机构
[1] DEPT CLIN GENET, LEEDS, W YORKSHIRE, ENGLAND
[2] ROYAL HOSP SICK CHILDREN, DEPT CHILD HLTH, GLASGOW G3 8SJ, LANARK, SCOTLAND
[3] ABERDEEN ROYAL HOSP, ABERDEEN, SCOTLAND
[4] NINEWELLS HOSP, DUNDEE DD1 9SY, SCOTLAND
关键词
Turner's syndrome; recombinant growth hormone; ring X; final height;
D O I
10.1111/j.1651-2227.1997.tb08858.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The aim of this work was to assess the outcome of recombinant growth hormone (rGH) therapy in a large unselected group (72) of patients with Turner's syndrome (TS), 26 of whom have reached final height. Growth data were collected from Scottish patients with TS and outcome was assessed in three ways: response to therapy in the first year, response in subsequent years and final height. Phenotypic, auxological, genetic and biochemical factors, all of which may have affected the first-year response, were investigated. Fifty-one percent of the cohort had a clinically ''good'' first-year response to therapy and 49% had a ''poor'' response; a ''good'' response was defined as a change in the TS standard deviation score (SDS) of +0.5 or more and a ''poor'' response as a change in the TS SDS of less than +0.5. The percentage of children showing a positive change in TS SDS after 2, 3 and 4 years of therapy declined (88%, 78%, 41%). Mean (range) final height was 142.6 (133.4-153.6)cm, mean (range) pretreatment TS SDS was -0.27 (-2.1 to +1.09) and mean (range) final TS SDS was -0.05 (-1.4 to +1.59). Thirteen (50%) patients attained a final height that was greater than projected, eleven did not attain their projected final height and two achieved their exact projected final height. Short girls with TS appear to benefit more from rGH supplementation than tall girls, but otherwise there was no significant correlation between any of the parameters studied and the response to treatment. It is concluded that large-scale prospective studies are still required to assess the impact of rGH on final height in TS and to identify factors responsible for the variability in response.
引用
收藏
页码:160 / 164
页数:5
相关论文
共 14 条
  • [1] POSSIBLE ROLE OF IMPRINTING IN THE TURNER PHENOTYPE
    CHU, CE
    DONALDSON, MDC
    KELNAR, CJH
    SMAIL, PJ
    GREENE, SA
    PATERSON, WF
    CONNOR, JM
    [J]. JOURNAL OF MEDICAL GENETICS, 1994, 31 (11) : 840 - 842
  • [2] Heinrichs C, 1995, INT CONGR SER, V1089, P137
  • [3] GROWTH CURVE FOR GIRLS WITH TURNER SYNDROME
    LYON, AJ
    PREECE, MA
    GRANT, DB
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1985, 60 (10) : 932 - 935
  • [4] TREATMENT WITH 2 GROWTH-HORMONE REGIMENS IN GIRLS WITH TURNER-SYNDROME - FINAL HEIGHT RESULTS
    MASSA, G
    OTTEN, BJ
    KEIZERSCHRAMA, SMPDM
    DELEMARREVANDEWAAL, HA
    JANSEN, M
    VULSMA, T
    OOSTDIJK, W
    WAELKENS, JJ
    WIT, JM
    [J]. HORMONE RESEARCH, 1995, 43 (04) : 144 - 146
  • [5] DEMOGRAPHY, AUXOLOGY AND RESPONSE TO RECOMBINANT HUMAN GROWTH-HORMONE TREATMENT IN GIRLS WITH TURNERS-SYNDROME IN THE KABI PHARMACIA INTERNATIONAL GROWTH STUDY
    PRICE, DA
    ALBERTSSONWIKLAND, K
    [J]. ACTA PAEDIATRICA, 1993, 82 : 69 - 74
  • [6] PREDICTION OF THE GROWTH-RESPONSE IN CHILDREN WITH VARIOUS GROWTH DISORDERS TREATED WITH GROWTH-HORMONE - ANALYSES OF DATA FROM THE KABI PHARMACIA INTERNATIONAL GROWTH STUDY
    RANKE, MB
    GUILBAUD, O
    LINDBERG, A
    COLE, T
    [J]. ACTA PAEDIATRICA, 1993, 82 : 82 - 88
  • [7] RANKE MB, 1988, ACTA PAEDIATR SCAND, P22
  • [8] STUDY OF FINAL HEIGHT IN TURNERS-SYNDROME - ETHNIC AND GENETIC INFLUENCES
    ROCHICCIOLI, P
    DAVID, M
    MALPUECH, G
    COLLE, M
    LIMAL, JM
    BATTIN, J
    MARIANI, R
    SULTAN, C
    NIVELON, JL
    SIMONIN, G
    BOST, M
    CHATELAIN, P
    BERTRAND, AM
    FREYCON, R
    BOUQUIER, JJ
    PIERRON, P
    [J]. ACTA PAEDIATRICA, 1994, 83 (03) : 305 - 308
  • [9] FINAL HEIGHT IN TURNER SYNDROME PATIENTS TREATED WITH GROWTH-HORMONE
    ROCHICCIOLI, P
    BATTIN, J
    BERTRAND, AM
    BOST, M
    CABROL, S
    LEBOUC, Y
    CHAUSSAIN, JL
    CHATELAIN, P
    COLLE, M
    CZERNICHOW, P
    DAVID, M
    JOB, JC
    LECORNU, M
    LEHEUP, B
    PIERSON, M
    LIMAL, JM
    MARIANI, R
    PONTE, C
    RAPPAPORT, R
    TAUBER, M
    [J]. HORMONE RESEARCH, 1995, 44 (04) : 172 - 176
  • [10] RONGENWESTERLAKEN C, 1991, INT CONGR SER, V924, P225